Ascorbic Acid and Quinone Combination for Chagas Disease
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Chagas disease, caused by Trypanosoma cruzi, are inadequate due to the toxicity and variable efficacy of existing drugs like benznidazole and nifurtimox, which cause significant side effects and do not effectively manage the chronic phase of the disease.
Innovation Solution
Administering a therapeutically effective amount of ascorbic acid and a quinone compound, such as vitamin K3, to inhibit parasitic growth and alleviate symptoms of Chagas disease, as shown by their synergistic effects on Trypanosoma cruzi forms, including epimastigote, trypomastigote, and amastigote forms, by increasing reactive oxygen species production and nitric oxide levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If benznidazole and nifurtimox are used to treat Chagas disease, then parasitic growth is inhibited, but toxicity and side effects increase
Solution Approach 1:
The patent combines ascorbic acid and a quinone compound into a single therapeutic formulation. This combination achieves synergistic effects where the sum of the individual effects is greater than the effect of either compound alone, thereby improving efficacy while reducing the toxicity associated with conventional single-agent treatments like benznidazole and nifurtimox.
Solution Approach 2:
The patent modifies the chemical and pharmacological parameters of the treatment by using ascorbic acid (a vitamin C derivative) and a quinone compound instead of conventional antiparasitic drugs. This parameter change results in a treatment with improved efficacy profile and reduced toxic effects, addressing the contradiction between effectiveness and safety.
2Reliability
If benznidazole and nifurtimox are used to treat Chagas disease, then parasitic growth is inhibited, but variable efficacy is observed
Solution Approach 1:
By merging ascorbic acid and a quinone compound into a combination therapy, the patent achieves more consistent and reliable efficacy across different patient populations and disease stages. The synergistic interaction between the two compounds provides a more predictable and adaptable treatment response compared to the variable efficacy observed with conventional single drugs.
3Ease of manufacture
If conventional drugs are used to treat Chagas disease, then treatment is provided, but high toxicity causes significant side effects
Solution Approach 1:
The patent employs ascorbic acid, a naturally occurring vitamin that is safe, inexpensive, and well-tolerated, combined with a quinone compound. This replacement of conventional toxic drugs with safer, more tolerable agents maintains treatment accessibility while dramatically reducing the harmful side effects and improving patient quality of life during treatment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of ascorbic acid and a quinone compound effectively inhibits parasitic growth and reduces oxidative stress, providing a potential alternative therapy with reduced toxicity and improved efficacy for treating Chagas disease.
Implementation Method 1
by increasing reactive oxygen species production and nitric oxide levels
Implementation Method 2
by increasing reactive oxygen species production and nitric oxide levels
Data Source
AI summary
Provided herein is a method of treating, preventing, or alleviating one or more symptoms of Chagas disease in a subject, comprising administering to the subject (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; and (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof.